Literature DB >> 9157946

No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.

P Pajukanta1, K V Porkka, M Antikainen, M R Taskinen, M Perola, S Murtomäki-Repo, S Ehnholm, I Nuotio, L Suurinkeroinen, A T Lahdenkari, A C Syvänen, J S Viikari, C Ehnholm, L Peltonen.   

Abstract

Familial combined hyperlipidemia (FCHL) is characterized by different lipid phenotypes (IIa, IIb, IV) and elevated apolipoprotein B (apo B) levels in affected family members. Despite intensive research, the genes involved in the expression of this complex disorder have not been identified, probably because of problems associated with phenotype definition, unknown mode of inheritance, and most probably genetic heterogeneity. To explore the genetics of FCHL in the genetically homogeneous Finnish population, we collected 14 well-documented Finnish pedigrees with premature coronary heart disease and FCHL-like dyslipidemia. The lipolytic enzymes lipoprotein lipase (LPL), hepatic lipase (HL), and hormone-sensitive lipase (HSL) were selected as initial candidate genes because of their central roles in apo B and triglyceride metabolism. On the basis of the pedigree structures, a dominant mode of inheritance was adopted for linkage analyses, and serum total cholesterol and/or triglyceride levels exceeding the 90th percentile level were set as diagnostic criteria (criterion 1). In pairwise linkage analyses with intragenic markers, no evidence for linkage was found. Instead, the significantly negative LOD scores suggested exclusion of all three loci for single major gene effect. LOD scores were -14.63, -5.03, and -5.70 for the three LPL polymorphisms (theta=0.00); -9.40, -6.30, and -4.74 for the three HL polymorphisms (theta=0.00); and -15.29 for the HSL polymorphism (theta=0.00). The results were very similar when apo B levels over the 90th percentile were used as criteria for affected status (criterion 2). Also, when linkage calculations were carried out using an intermediate or recessive mode of inheritance, the results of pairwise linkage analysis remained negative. Furthermore, when haplotypes were constructed from multiple polymorphisms of the LPL and HL genes, no segregation with the FCHL phenotype could be observed in the 14 Finnish families. Data obtained by the affected sib-pair method supported these findings, suggesting that the LPL, HL, or HSL genes do not represent major loci influencing the expression of the FCHL phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157946     DOI: 10.1161/01.atv.17.5.841

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  Quantitative-trait-locus analysis of body-mass index and of stature, by combined analysis of genome scans of five Finnish study groups.

Authors:  M Perola; M Ohman; T Hiekkalinna; J Leppävuori; P Pajukanta; M Wessman; M Koskenvuo; A Palotie; K Lange; J Kaprio; L Peltonen
Journal:  Am J Hum Genet       Date:  2001-06-15       Impact factor: 11.025

Review 3.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 4.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

5.  Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families.

Authors:  Ellen M Wijsman; Joseph H Rothstein; Robert P Igo; John D Brunzell; Arno G Motulsky; Gail P Jarvik
Journal:  Hum Genet       Date:  2010-04-11       Impact factor: 4.132

6.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Authors:  B E Aouizerat; H Allayee; R M Cantor; R C Davis; C D Lanning; P Z Wen; G M Dallinga-Thie; T W de Bruin; J I Rotter; A J Lusis
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

7.  Galanin preproprotein is associated with elevated plasma triglycerides.

Authors:  Christopher L Plaisier; Mira Kyttälä; Daphna Weissglas-Volkov; Janet S Sinsheimer; Adriana Huertas-Vazquez; Laura Riba; Salvador Ramírez-Jiménez; Tjerk W A de Bruin; Teresa Tusié-Luna; Bradley E Aouizerat; Clive R Pullinger; Mary J Malloy; John P Kane; Ivette Cruz-Bautista; Miguel F Herrera; Carlos Aguilar-Salinas; Johanna Kuusisto; Markku Laakso; Marja-Riitta Taskinen; Carla J H van der Kallen; Päivi Pajukanta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-06       Impact factor: 8.311

Review 8.  Genetics of familial combined hyperlipidemia.

Authors:  P Pajukanta; K V Porkka
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.